Erratum: Tetanus antigen modulates the gene expression profile of aluminium phosphate adjuvant in spleen lymphocytes in vivo.
- Published in:
- 2002
- By:
- Publication type:
- Correction Notice
Works matching IS 1470269X AND DT 2002 AND VI 2 AND IP 3
Results: 14
1
2
Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 284, doi. 10.1038/sj.tpj.6500131
- By:
- Publication type:
- Article
3
Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 197, doi. 10.1038/sj.tpj.6500101
- By:
- Publication type:
- Article
4
A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 191, doi. 10.1038/sj.tpj.6500099
- By:
- Publication type:
- Article
5
The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 182, doi. 10.1038/sj.tpj.6500100
- By:
- Publication type:
- Article
6
Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 176, doi. 10.1038/sj.tpj.6500090
- By:
- Publication type:
- Article
7
Merlin: faster linkage analysis with improved genotyping error detection.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 139, doi. 10.1038/sj.tpj.6500102
- By:
- Publication type:
- Article
8
Linkage disequilibrium mapping identifies a 390 kb region associated with CYP2D6 poor drug metabolising activity.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 165, doi. 10.1038/sj.tpj.6500096
- By:
- Publication type:
- Article
9
NAT--from bugs to brains An overview of the 2nd International Workshop on the arylamine N-acetyltransferases.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 152, doi. 10.1038/sj.tpj.6500114
- By:
- Publication type:
- Article
10
Implications of pharmacogenomics in oral health.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 148, doi. 10.1038/sj.tpj.6500107
- By:
- Publication type:
- Article
11
Pharmacogenomics and the challenge to privacy.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 144, doi. 10.1038/sj.tpj.6500110
- By:
- Publication type:
- Article
12
The challenges of delivering pharmacogenomics into clinical pediatrics.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 141, doi. 10.1038/sj.tpj.6500104
- By:
- Publication type:
- Article
13
An international database and integrated analysis tools for teh study of cancer gene expression.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 3, p. 156, doi. 10.1038/sj.tpj.6500103
- By:
- Publication type:
- Article
14
Patient-oriented investigation in pharmacogenomics.
- Published in:
- 2002
- By:
- Publication type:
- Editorial